Suppr超能文献

用于抗体检测的斑点酶联免疫吸附测定法的标准化与验证

Standardization and validation of Dot-ELISA assay for antibody detection.

作者信息

Kamikawa Camila Mika, Mendes Rinaldo Poncio, Vicentini Adriana Pardini

机构信息

Laboratory of Mycosis Immunodiagnosis, Center of Immunology, Adolfo Lutz Institute, Av. Dr. Arnaldo, 355, 11o andar, sala 1117 São Paulo, SP Brazil.

Graduate Program in Sciences, Disease Control Coordination of the São Paulo State Health Secretariat, São Paulo, SP Brazil.

出版信息

J Venom Anim Toxins Incl Trop Dis. 2017 Feb 15;23:11. doi: 10.1186/s40409-017-0101-3. eCollection 2017.

Abstract

BACKGROUND

Paracoccidioidomycosis (PCM) is a neglected systemic mycosis caused by a dimorphic fungus of the genus. The standard diagnosis is based on isolation of the fungi in culture, and by microscopic visualization of characteristic multiple budding yeast cells in biological samples. However, in some situations, access to the site of injury prevents the collection of biological material. A variety of immuno-serological techniques has proven useful for allowing inferring diagnosis with a certain degree of certainty, thus optimizing time. The aim of this study was to standardize and validate the Dot-ELISA (DE) assay, comparing it with the serological standard, double immunodiffusion (DI).

METHODS

In order to standardize the DE assay, 143 serum samples were used. Out of those, 23 were from apparently healthy patients, 77 were from patients with confirmed PCM and 43 were from patients with other lung infections (tuberculosis, aspergillosis and histoplasmosis). To validate the DE technique, 300 serum samples from patients with PCM clinical suspicion (probable and possible cases) were employed, and these results were compared with those of DI.

RESULTS

The DE assay showed sensitivity of 91%, specificity of 95.4%, positive predictive value of 96%, negative predictive value of 98.2%, accuracy of 93%, and great precision (k = 0.93). In addition, the nitrocellulose membranes have proved to be viable for using at least 90 days after B-339 antigen sensitization.

CONCLUSION

Dot-ELISA method was found to be an extremely promising tool as serologic screening technique, because of its high sensitivity. Furthermore, Dot-ELISA shows the prospect of being transferred to laboratories of mycoserology including those with fewer resources or even to be used directly in the field. It has an excellent shelf life - membranes coated with antigen can be used for testing without changes in the pattern of reactivity among laboratories - and presents reliable values of sensitivity, specificity, predictive values, accuracy and a high correlation with the serological standard methodology. Based on the present findings, it possible to state that this technique constitutes a remarkable option to be used in routine diagnosis for public health centers.

摘要

背景

副球孢子菌病(PCM)是一种由该属双相真菌引起的被忽视的系统性真菌病。标准诊断基于真菌在培养物中的分离,以及在生物样本中通过显微镜观察特征性的多个芽生酵母细胞。然而,在某些情况下,由于无法获取损伤部位,导致无法采集生物材料。各种免疫血清学技术已被证明有助于在一定程度上推断诊断,从而优化时间。本研究的目的是标准化和验证斑点酶联免疫吸附测定(Dot-ELISA),并将其与血清学标准方法双向免疫扩散(DI)进行比较。

方法

为了标准化Dot-ELISA测定,使用了143份血清样本。其中,23份来自明显健康的患者,77份来自确诊的PCM患者,43份来自其他肺部感染(结核病、曲霉病和组织胞浆菌病)患者。为了验证Dot-ELISA技术,采用了300份临床怀疑患有PCM的患者(可能和疑似病例)的血清样本,并将这些结果与DI的结果进行比较。

结果

Dot-ELISA测定显示敏感性为91%,特异性为95.4%,阳性预测值为96%,阴性预测值为98.2%,准确性为93%,且具有很高的精密度(k = 0.93)。此外,已证明硝酸纤维素膜在B-339抗原致敏后至少90天仍可使用。

结论

由于其高敏感性,Dot-ELISA方法被发现是一种极具前景的血清学筛查技术。此外,Dot-ELISA显示出有望转移到包括资源较少的实验室在内的真菌血清学实验室,甚至可直接在现场使用。它具有出色的保质期——涂有抗原的膜可用于检测,不同实验室之间的反应模式没有变化——并呈现出可靠的敏感性、特异性、预测值、准确性值,且与血清学标准方法高度相关。基于目前的研究结果,可以说该技术是公共卫生中心常规诊断中一个显著的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3834/5312266/8c281541a844/40409_2017_101_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验